Nicholas Focil
- Chairman and Founder at AlzWell
GetLatka interview
How Febo Health Reached 14,000 App Downloads and Closed a $106K SAFE Round at a $4M Valuation (Interview with Chairman and Founder Nicholas Focil)
Nicholas Focil (Chairman and Founder of Febo Health) spoke to Nathan Latka on February 2, 2022.
Febo Health figures from the interview
- SAFE Round 1 Valuation (2022)
- $4,000,000
- SAFE Round Raised (2022)
- $106,000
- App Downloads (2022)
- 14,000
- Investor Equity (2022)
- 3%
- Founder Equity (2022)
- 82%
“Right now, it's entirely embedded. There's no revenue. There is we're not looking to make any money on it for about the next two to three years. It's entirely gonna be funded for for growth at this point.”
“It was a 106,000, safe round one at $4,000,000 valuation.”
“So this is a byproduct of my company, FOMAT Medical Research, the one I'm CEO for, and that's been it's a product of it. So it's been paying salaries.”
Bio
Nicholas Focil is the Chairman & Founder of Febo, a Health ToolBox SaaS app used globally by chronic condition patients to help make life a little easier. After attaining his Biochemistry degree, he worked in several positions and is the CEO of FOMAT Medical Research in addition to his role at Febo.